Skip to main content
. 2015 Dec 28;11:238–390. doi: 10.1111/j.1469-0691.2005.clm_1134_02.x

Table 1.

includes comparisons of cost, duration of therapy and LOS. Predictably, patients receiving LZD in the hospital had higher drug costs; however, a decreased LOS contributed to a $7000 lower cost of hospitalization.

Table 1 Linezolid (n=26) Mean +/− S D Median [range] Vancomycin (n=52) Mean +/− SD Median [range] P
Hospital LOS (days)

  • 15 +/− 11

  • 12.5 [2–58]

  • 22 +/− 16

  • 21 [5–105]

 .028
Antibiotic-related LOS (days)

  • 15 +/− 11

  • 12 [2–55]

  • 14 +/− 7

  • 12 [5–33]

 NS
IV tx in hospital (days)

  • 12 +/− 11

  • 9.5 [2–54]

  • 14 +/− 7

  • 11 [5–30]

 NS
PO tx in hospital (days)

  • 3 +/− 3

  • 3 [0–15]

  • 0.7 +/−2

  • 0 [0–7]

 <.001
PO tx at home (days)

  • 13 +/− 11

  • 10 [0–48]

  • 3 +/− 6

  • 0 [0–28]

 <.001
IV tx at home (days)

  • 0

  • 0 [0–0]

  • 11 +/−16

  • 0 [0–48]

 <.001
In-hospital antibiotic costs (US$)

  • 485 +/− 480

  • 350 [55–1975]

  • 150 +/− 150

  • 110 [20–805]

 <.001
Cost of hospitalization (US$)

  • 12,900 +/− 9900

  • 10,600 [1700–49,000]

  • 19,000 +/− 14,300

  • 17,900 [4200–89,400]

 .027